This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Pulmonary Hypertension
and you are
between 18 and 65
years old
The phase for this study is not defined.
Show me locations

The purpose

Pulmonary arterial hypertension (PAH) is a progressive disease of the pulmonary vasculature leading to elevated pulmonary pressure and right ventricular (RV) dysfunction with heart failure. Measures of RV function are better predictors of mortality and long term outcomes than pulmonary vascular resistance. The interaction between RV function and the pulmonary circulation is not fully understood, but increased after load appears insufficient to explain right heart failure. Yet, all approved PAH therapies target vasodilation of the pulmonary vasculature to lower pressures

Provided treatments

  • Drug: Carvedilol
  • Drug: placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01586156. The sponsor of the trial is The Cleveland Clinic and it is looking for 30 volunteers for the current phase.
Official trial title:
Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure